Glucocorticoids treatment upregulates the expression of CD62L in CD4+CD25+T cells in peripheral blood monocytes of patients with systemic lupus erythematosus
TAN Guo-zhen1, PENG Hui2, MAO Yue-ping1, ZENG Fan-qin1
Department of Dermatology, Second Affiliated Hospital of Zhongshan University, Guangzhou 510120, China
TAN Guo-zhen, PENG Hui, MAO Yue-ping, ZENG Fan-qin. Glucocorticoids treatment upregulates the expression of CD62L in CD4+CD25+T cells in peripheral blood monocytes of patients with systemic lupus erythematosus[J].Chinese Journal of Dermatology, 2007, 40(6): 362-364.
[1] Smolen JS.Therapy of systemic lupus erythematosus:a look into the future.Arthritis Res,2002,Suppl 3:S25-30. [2] Szanya V,Ermann J,Taylor C,et al.The subpopulatiou of CD4+ CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7.J Immunol.2002,169(5):2461-2465. [3] Ermann J,Hoffmann P,Edinger M,et al.Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD.Blood,2005,105(5):2220-2226. [4] Butcher EC,Picker LJ.Lymphocyte homing and homeostasis.Science,1996,272(5258):60-66. [5] 陈朗,吴春晨,何玉玲,等.系统性红斑狼疮患者CCR7+CD8+CD45RO+T细胞诱导CD4+T细胞向Th2分化.中华皮肤科杂志,2005,38(6):374-376. [6] 彭辉,谭国珍,吴长有.糖皮质激素治疗对SLE患者外周血CD4+CD25+T细胞亚群的影响.中国免疫学杂志,2005,21(2):83-85. [7] 游弋,郝飞,邓永健.糖皮质激素对SLE患者CD4+、CD8+T细胞Caspase-3及TRAIL受体基因表达的影响.中华皮肤科杂志,2007,40(1):19-21.